Brief: Captor Therapeutics Obtains Results Of Additional In-Vivo Tests Regarding CT-01 Project

Captor Therapeutics SA

19/04/2022 14:52

April 19 (Reuters) - Captor Therapeutics SA  CTXP.WA :
    * COMPANY OBTAINED RESULTS OF ADDITIONAL IN-VIVO TESTS
REGARDING
CT-01 PROJECT
    * RESULTS CONFIRM THAT ORAL ADMINISTRATION OF COMPOUNDS OF
CT-01
PROJECT RESULT IN COMPLETE DISAPPEARANCE (REGRESSION) OF
HEPATOCELLULAR CARCINOMA TUMOR IN MOUSE MODEL HEP3B2.1-7

Source text for Eikon:  ID:nEMphfNGa 
Further company coverage:  CTXP.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))